Slide Deck

Coordinating Center Updates

Presenter: Nicole Rioles, MA

  • Abstract submissions:
    • T1DX submitted 14 abstracts to ADA.
    • An additional 5 late-breaking abstracts will be submitted.
  • 2026 Annual Survey Questions:
    • Proposals due May 1.
  • Learning Session abstracts will be published next month in the Journal of Diabetes.

Screening and Monitoring Update

  • Overview of the Beta Cell Preservation Work Group.
  • The white paper has been developed and will be available for dissemination by February 23 on the T1D Exchange website.
  • Discussion question: Are adult centers considering workflow changes to incorporate increased Tzield use?

Center Presentation: OHSU

Presenters: Farahnaz Joarder, MD; Ryan Tweet, PsyD

Topic: Screening Diabetes Distress: Evolution of the OHSU Experience

  • Overview of diabetes distress and its impact on health outcomes.
  • Introduction of the Type 1 Diabetes Distress Assessment System (T1-DDAS).
  • Project timeline: March 2022 – December 2025.
  • Dr. Joarder reviewed:
    • Distribution of the correct questionnaire and completion processes.
    • OHSU’s clinical workflow.
    • Use of fishbone diagrams to identify barriers.
  • Dr. Tweet presented questionnaire completion trends at OHSU.
  • Provider experience:
    • Concerns related to time constraints and addressing behavioral health needs.
    • Diabetes distress provider workshops reviewed (past and upcoming).
  • Current focus (2025–2026):
    • Evaluating how screening data is used in real clinical visits.
    • Refining who receives the questionnaire and how often.
    • Ongoing workflow review to reduce burden on patients and providers.
  • Distribution detail: Patients receive the T1-DDAS via MyChart 7 days prior to their appointment.
  • Please contact: joarder@ohsu.edu or tweet@ohsu.edu for questions or feedback.

Center Presentation: University Hospitals Cleveland Medical Center

Presenter: Clare Kelly, MD

Topic: Screening for and Detecting Depression in Diabetes

  • ADA 2026 Standards of Care: Recommend screening for depressive symptoms in all people with diabetes.
  • Rationale:
    • Approximately 1 in 4 people with diabetes are affected by depression.
    • Depressive symptoms are associated with poorer health outcomes.
    • Negative correlation exists between depression and self-care behaviors.
  • Prior to this project, depression screening was conducted as needed with no established interval.
Project Aim:
  • Within six months, implement a routine depression screening protocol.
  • Screen 90% of adult patients with type 1 diabetes during visits.
  • Fishbone diagrams identified barriers to depression screening.
  • Outcome: Screening rates reached approximately 80%, short of the 90% goal.
  • Impact of a positive PHQ-9: For scores ≥7, multiple follow-up pathways were initiated.
Key learnings discussed:
  • What worked well.
    • What required adjustment.
    • Practical insights for replication.
  • Rationale for visit-based screening was reviewed.
Future directions:
  • Expansion to additional clinical sites.
  • Increased collaboration with mental health clinical partners.

Q&A

  • Julia Blanchette, RN, PhD shared information regarding Blue Circle Health
  • UH requested tips related to Epic implementation; they have been live for less than two years.
  • Participants encouraged to reach out to UH with guidance or shared experience.